InsiderClue
← All stocks

Entrada Therapeutics, Inc.

TRDA Net buying
CIK 0001689375 #3614 in the set updated 17 Sep 2026
Bought (120 mo)
$39.31M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$25.92M
$3.46M on a plan · $2.85M straight out of an exercise
Sold at will
$19.61M
110 of 217 sales
Net
+$13.39M
+$19.70M against sales at will

By person

16 insiders · 282 transactions
5.8×

Dipal Doshi holds 5.8 times base salary in stock. $3.69M of shares against $635.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dipal Doshi last reported holding, valued at $7.13, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Redmile Group, LLC entity
10% owner
$20.00M (1)
—
+$20.00M
1,954,420
5.02%
$13.94M
—
BAKER BROS. ADVISORS LP entity
10% owner
$2.59M (40)
—
+$2.59M
4,691,392
12.05%
$33.45M
+8.5%
MPM BioVentures 2014, L.P.
10% owner
$2.00M (1)
$4.52M (14)
−$2.52M
8,203,463
21.07%
$58.49M
+90.0%
MPM BIOVENTURES 2018, L.P.
10% owner
$2.00M (1)
$4.52M (14)
−$2.52M
8,203,463
21.07%
$58.49M
+90.0%
Foley Todd
Director
$2.00M (1)
—
+$2.00M
4,425,784
11.37%
$31.56M
—
WENTWORTH KORY JAMES
Chief Financial Officer
—
$1.91M (37) scheduled
−$1.91M
117,277
0.3012%
$836.19K
—
Sethuraman Natarajan
President, Research & Develop.
—
$1.90M (21) scheduled
−$1.90M
214,238
0.5502%
$1.53M
+64.1%
Dowden Nathan J
President & COO
—
$1.90M (31) scheduled
−$1.90M
196,060
0.5035%
$1.40M
+315.9%
Doshi Dipal
CEO
—
$1.39M (49)
−$1.39M
517,290
1.33%
$3.69M
+314.5%
KREHER NERISSA
Chief Medical Officer
—
$998.17K (24) scheduled
−$998.17K
40,037
0.1028%
$285.46K
—
5AM Ventures V, L.P. entity
10% owner
$5.00M (1)
$4.07M (13)
+$931.96K
3,877,094
9.96%
$27.64M
+1,071%
KIM PETER S
Director
$641.94K (11)
—
+$641.94K
104,330
0.2679%
$743.87K
+121.8%
PARMAR KUSH
Director
$5.00M (1)
$4.72M (14)
+$284.85K
2,691,337
6.91%
$19.19M
—
Crowley John F
Director
$48.58K (1)
—
+$48.58K
5,000
0.0128%
$35.65K
—
Zeiher Bernhardt G
Director
$29.32K (1)
—
+$29.32K
5,000
0.0128%
$35.65K
—
ROCHE HOLDING LTD entity
10% owner
—
—
—
2,813,525
7.23%
$20.06M
—

Individual transactions

62
Insider
Date
Role
Action
Shares
Price
Amount
Sethuraman Natarajan
4 May 2026
President, Research & Develop.
Sold on a plan
25,907
$15.39
$398.81K
WENTWORTH KORY JAMES
1 Apr 2026
Chief Financial Officer
Sold on a plan
2,500
$12.95
$32.38K
WENTWORTH KORY JAMES
10 Mar 2026
Chief Financial Officer
Sold on a plan
11,388
$13.02
$148.22K
Dowden Nathan J
10 Mar 2026
President & COO
Sold on a plan
11,894
$13.05
$155.19K
WENTWORTH KORY JAMES
9 Mar 2026
Chief Financial Officer
Sold on a plan
5,089
$13.00
$66.16K
Dowden Nathan J
9 Mar 2026
President & COO
Sold on a plan
3,116
$13.02
$40.58K
WENTWORTH KORY JAMES
4 Mar 2026
Chief Financial Officer
Sold on a plan
7,988
$12.25
$97.89K
WENTWORTH KORY JAMES
21 Nov 2025
Chief Financial Officer
Sold on a plan
8,910
$9.98
$88.93K
WENTWORTH KORY JAMES
17 Mar 2025
Chief Financial Officer
Sold on a plan
1,784
$10.67
$19.04K
Sethuraman Natarajan
3 Dec 2024
President, Research & Develop.
Sold on a plan
11,703
$20.15
$235.79K
Sethuraman Natarajan
2 Dec 2024
President, Research & Develop.
Sold on a plan
4,088
$20.26
$82.83K
Sethuraman Natarajan
29 Nov 2024
President, Research & Develop.
Sold on a plan
100
$20.00
$2.00K
Sethuraman Natarajan
13 Nov 2024
President, Research & Develop.
Sold on a plan
2,700
$20.04
$54.11K
Sethuraman Natarajan
11 Nov 2024
President, Research & Develop.
Sold on a plan
1,409
$20.01
$28.19K
Sethuraman Natarajan
6 Nov 2024
President, Research & Develop.
Sold on a plan
2,745
$19.32
$53.02K
Sethuraman Natarajan
6 Nov 2024
President, Research & Develop.
Sold on a plan
9,554
$18.71
$178.75K
Sethuraman Natarajan
5 Nov 2024
President, Research & Develop.
Sold on a plan
5,171
$18.18
$94.01K
Sethuraman Natarajan
4 Nov 2024
President, Research & Develop.
Sold on a plan
749
$18.02
$13.50K
Sethuraman Natarajan
16 Oct 2024
President, Research & Develop.
Sold on a plan
600
$18.00
$10.80K
Dowden Nathan J
26 Sep 2024
President & COO
Sold on a plan
847
$16.00
$13.55K
Sethuraman Natarajan
9 Sep 2024
Chief Scientific Officer
Sold on a plan
2,642
$15.09
$39.86K
Dowden Nathan J
9 Sep 2024
President & COO
Sold on a plan
1,904
$15.07
$28.69K
WENTWORTH KORY JAMES
9 Sep 2024
Chief Financial Officer
Sold on a plan
3,195
$14.97
$47.83K
Sethuraman Natarajan
6 Sep 2024
Chief Scientific Officer
Sold on a plan
600
$15.24
$9.14K
Dowden Nathan J
6 Sep 2024
President & COO
Sold on a plan
399
$15.19
$6.06K
Doshi Dipal
15 Jul 2024
CEO
Sold on a plan
1,600
$17.81
$28.50K
Sethuraman Natarajan
15 Jul 2024
Chief Scientific Officer
Sold on a plan
638
$18.00
$11.48K
Doshi Dipal
12 Jul 2024
CEO
Sold on a plan
300
$18.00
$5.40K
Sethuraman Natarajan
12 Jul 2024
Chief Scientific Officer
Sold on a plan
600
$18.00
$10.80K
WENTWORTH KORY JAMES
8 Jul 2024
Chief Financial Officer
Sold on a plan
1,758
$14.95
$26.28K
Doshi Dipal
13 Jun 2024
CEO
Sold on a plan
1,000
$16.17
$16.17K
Sethuraman Natarajan
20 May 2024
Chief Scientific Officer
Sold on a plan
9,675
$15.19
$146.94K
Doshi Dipal
17 May 2024
CEO
Sold on a plan
1,200
$15.11
$18.13K
Sethuraman Natarajan
17 May 2024
Chief Scientific Officer
Sold on a plan
8,305
$15.14
$125.75K
Doshi Dipal
16 May 2024
CEO
Sold on a plan
1,800
$15.00
$27.00K
Sethuraman Natarajan
16 May 2024
Chief Scientific Officer
Sold on a plan
1,000
$15.00
$15.00K
Dowden Nathan J
6 Mar 2024
President & COO
Sold on a plan
1,826
$12.32
$22.50K
WENTWORTH KORY JAMES
6 Mar 2024
Chief Financial Officer
Sold on a plan
4,086
$12.31
$50.29K
Doshi Dipal
15 Feb 2024
CEO
Sold on a plan
1,000
$15.00
$15.00K
Doshi Dipal
16 Jan 2024
CEO
Sold on a plan
1,000
$15.99
$15.99K
Doshi Dipal
20 Dec 2023
President and CEO
Sold on a plan
1,000
$15.00
$15.00K
Doshi Dipal
13 Nov 2023
President and CEO
Sold on a plan
1,000
$16.23
$16.23K
Doshi Dipal
17 Oct 2023
President and CEO
Sold on a plan
1,000
$15.00
$15.00K
Doshi Dipal
13 Sep 2023
President and CEO
Sold on a plan
1,000
$15.00
$15.00K
Dowden Nathan J
6 Sep 2023
Chief Operating Officer
Sold on a plan
59
$14.01
$826.41
Dowden Nathan J
6 Sep 2023
Chief Operating Officer
Sold on a plan
913
$13.43
$12.26K
KREHER NERISSA
6 Sep 2023
Chief Medical Officer
Sold on a plan
21
$14.00
$294.00
KREHER NERISSA
6 Sep 2023
Chief Medical Officer
Sold on a plan
871
$13.46
$11.73K
WENTWORTH KORY JAMES
6 Sep 2023
Chief Financial Officer
Sold on a plan
46
$14.03
$645.38
WENTWORTH KORY JAMES
6 Sep 2023
Chief Financial Officer
Sold on a plan
904
$13.45
$12.16K
Doshi Dipal
14 Aug 2023
President and CEO
Sold on a plan
1,000
$15.67
$15.67K
Sethuraman Natarajan
11 Jul 2023
Chief Scientific Officer
Sold on a plan
14,852
$18.04
$267.92K
Dowden Nathan J
11 Jul 2023
Chief Operating Officer
Sold on a plan
3,897
$18.05
$70.33K
Sethuraman Natarajan
10 Jul 2023
Chief Scientific Officer
Sold on a plan
3,026
$18.00
$54.47K
Dowden Nathan J
10 Jul 2023
Chief Operating Officer
Sold on a plan
3,200
$18.00
$57.61K
Dowden Nathan J
22 Jun 2023
Chief Operating Officer
Sold on a plan
7,097
$16.02
$113.70K
Dowden Nathan J
20 Jun 2023
Chief Operating Officer
Sold on a plan
8,885
$14.94
$132.70K
Doshi Dipal
27 Apr 2023
President and CEO
Sold on a plan
2,000
$13.71
$27.42K
Sethuraman Natarajan
17 Apr 2023
Chief Scientific Officer
Sold on a plan
3,961
$18.00
$71.32K
Doshi Dipal
17 Apr 2023
President and CEO
Sold on a plan
2,092
$18.01
$37.68K
Doshi Dipal
27 Mar 2023
President and CEO
Sold on a plan
200
$15.51
$3.10K
Doshi Dipal
27 Mar 2023
President and CEO
Sold on a plan
1,800
$14.63
$26.33K
Showing 250 of 282 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 215
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 26
Sales on a Rule 10b5-1 plan 62
Sales straight out of an exercise 45
Sales at will 110
Transactions with no price 0
Shares from compensation/vesting 26,064,466
Sales filed before the plan box existed 55
History held since 1 Nov 2021